nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A4—Thiotepa—urinary bladder cancer	0.104	0.235	CbGbCtD
Dextropropoxyphene—CYP2C8—Fluorouracil—urinary bladder cancer	0.0835	0.188	CbGbCtD
Dextropropoxyphene—CYP2C8—Etoposide—urinary bladder cancer	0.0697	0.157	CbGbCtD
Dextropropoxyphene—CYP2C9—Fluorouracil—urinary bladder cancer	0.0583	0.131	CbGbCtD
Dextropropoxyphene—CYP2C9—Cisplatin—urinary bladder cancer	0.0495	0.112	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—urinary bladder cancer	0.0303	0.0684	CbGbCtD
Dextropropoxyphene—CYP3A4—Etoposide—urinary bladder cancer	0.0283	0.0638	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—urinary bladder cancer	0.0193	0.0435	CbGbCtD
Dextropropoxyphene—Benzphetamine—POR—urinary bladder cancer	0.00432	0.44	CrCbGaD
Dextropropoxyphene—Toremifene—ESR1—urinary bladder cancer	0.00227	0.231	CrCbGaD
Dextropropoxyphene—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00166	0.00404	CcSEcCtD
Dextropropoxyphene—Vision blurred—Thiotepa—urinary bladder cancer	0.00165	0.00401	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.00162	0.00392	CcSEcCtD
Dextropropoxyphene—Agitation—Thiotepa—urinary bladder cancer	0.00161	0.00391	CcSEcCtD
Dextropropoxyphene—Bradycardia—Cisplatin—urinary bladder cancer	0.00161	0.0039	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.00159	0.00386	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Etoposide—urinary bladder cancer	0.00158	0.00384	CcSEcCtD
Dextropropoxyphene—Coma—Methotrexate—urinary bladder cancer	0.00158	0.00383	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00157	0.00382	CcSEcCtD
Dextropropoxyphene—Jaundice—Etoposide—urinary bladder cancer	0.00157	0.00382	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Gemcitabine—urinary bladder cancer	0.00153	0.00372	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00153	0.00371	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00152	0.0037	CcSEcCtD
Dextropropoxyphene—Visual impairment—Cisplatin—urinary bladder cancer	0.00152	0.0037	CcSEcCtD
Dextropropoxyphene—Convulsion—Thiotepa—urinary bladder cancer	0.00152	0.00369	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Gemcitabine—urinary bladder cancer	0.00151	0.00368	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00149	0.00363	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Fluorouracil—urinary bladder cancer	0.00149	0.00361	CcSEcCtD
Dextropropoxyphene—Eye disorder—Cisplatin—urinary bladder cancer	0.00148	0.00358	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—urinary bladder cancer	0.00148	0.00358	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ESR2—urinary bladder cancer	0.00147	0.15	CrCbGaD
Dextropropoxyphene—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00147	0.00356	CcSEcCtD
Dextropropoxyphene—Confusional state—Thiotepa—urinary bladder cancer	0.00144	0.0035	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Cisplatin—urinary bladder cancer	0.00143	0.00346	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00142	0.00346	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Cisplatin—urinary bladder cancer	0.00141	0.00343	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Thiotepa—urinary bladder cancer	0.0014	0.00341	CcSEcCtD
Dextropropoxyphene—Tachycardia—Thiotepa—urinary bladder cancer	0.0014	0.00339	CcSEcCtD
Dextropropoxyphene—Malnutrition—Cisplatin—urinary bladder cancer	0.00137	0.00334	CcSEcCtD
Dextropropoxyphene—Vision blurred—Fluorouracil—urinary bladder cancer	0.00137	0.00332	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—urinary bladder cancer	0.00137	0.00332	CcSEcCtD
Dextropropoxyphene—Eye disorder—Etoposide—urinary bladder cancer	0.00135	0.00328	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Etoposide—urinary bladder cancer	0.00134	0.00326	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—urinary bladder cancer	0.00134	0.00326	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Methotrexate—urinary bladder cancer	0.00132	0.00321	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Etoposide—urinary bladder cancer	0.00131	0.00317	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Etoposide—urinary bladder cancer	0.0013	0.00317	CcSEcCtD
Dextropropoxyphene—Vision blurred—Cisplatin—urinary bladder cancer	0.0013	0.00315	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.00129	0.00314	CcSEcCtD
Dextropropoxyphene—Somnolence—Thiotepa—urinary bladder cancer	0.00127	0.00309	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Thiotepa—urinary bladder cancer	0.00126	0.00306	CcSEcCtD
Dextropropoxyphene—Convulsion—Fluorouracil—urinary bladder cancer	0.00126	0.00305	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—urinary bladder cancer	0.00124	0.00301	CcSEcCtD
Dextropropoxyphene—Discomfort—Gemcitabine—urinary bladder cancer	0.00124	0.00301	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00124	0.003	CcSEcCtD
Dextropropoxyphene—Constipation—Thiotepa—urinary bladder cancer	0.00122	0.00297	CcSEcCtD
Dextropropoxyphene—Discomfort—Fluorouracil—urinary bladder cancer	0.00122	0.00296	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.0012	0.00291	CcSEcCtD
Dextropropoxyphene—Confusional state—Fluorouracil—urinary bladder cancer	0.00119	0.0029	CcSEcCtD
Dextropropoxyphene—Convulsion—Cisplatin—urinary bladder cancer	0.00119	0.00289	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00118	0.00287	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00118	0.00286	CcSEcCtD
Dextropropoxyphene—Ataxia—Methotrexate—urinary bladder cancer	0.00118	0.00286	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00117	0.00285	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00117	0.00284	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00116	0.00282	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.00116	0.00281	CcSEcCtD
Dextropropoxyphene—Discomfort—Cisplatin—urinary bladder cancer	0.00116	0.00281	CcSEcCtD
Dextropropoxyphene—Tachycardia—Fluorouracil—urinary bladder cancer	0.00116	0.00281	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Thiotepa—urinary bladder cancer	0.00113	0.00275	CcSEcCtD
Dextropropoxyphene—Hypotension—Gemcitabine—urinary bladder cancer	0.00112	0.00273	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00111	0.00271	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Etoposide—urinary bladder cancer	0.00111	0.00269	CcSEcCtD
Dextropropoxyphene—Hypotension—Fluorouracil—urinary bladder cancer	0.00111	0.00269	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—urinary bladder cancer	0.0011	0.00268	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Cisplatin—urinary bladder cancer	0.0011	0.00267	CcSEcCtD
Dextropropoxyphene—Tachycardia—Cisplatin—urinary bladder cancer	0.0011	0.00266	CcSEcCtD
Dextropropoxyphene—Convulsion—Etoposide—urinary bladder cancer	0.00109	0.00265	CcSEcCtD
Dextropropoxyphene—Insomnia—Gemcitabine—urinary bladder cancer	0.00109	0.00264	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.00108	0.00263	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.00108	0.00263	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00107	0.00261	CcSEcCtD
Dextropropoxyphene—Insomnia—Fluorouracil—urinary bladder cancer	0.00107	0.0026	CcSEcCtD
Dextropropoxyphene—Somnolence—Gemcitabine—urinary bladder cancer	0.00107	0.0026	CcSEcCtD
Dextropropoxyphene—Discomfort—Etoposide—urinary bladder cancer	0.00106	0.00257	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00106	0.00256	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00105	0.00256	CcSEcCtD
Dextropropoxyphene—Somnolence—Fluorouracil—urinary bladder cancer	0.00105	0.00256	CcSEcCtD
Dextropropoxyphene—Hypotension—Cisplatin—urinary bladder cancer	0.00105	0.00255	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00104	0.00253	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00104	0.00252	CcSEcCtD
Dextropropoxyphene—Confusional state—Etoposide—urinary bladder cancer	0.00104	0.00252	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.00103	0.00251	CcSEcCtD
Dextropropoxyphene—Constipation—Gemcitabine—urinary bladder cancer	0.00103	0.0025	CcSEcCtD
Dextropropoxyphene—Asthenia—Thiotepa—urinary bladder cancer	0.00103	0.00249	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00102	0.00248	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—urinary bladder cancer	0.00102	0.00248	CcSEcCtD
Dextropropoxyphene—Tachycardia—Etoposide—urinary bladder cancer	0.001	0.00244	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.001	0.00243	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Cisplatin—urinary bladder cancer	0.001	0.00243	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000992	0.00241	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Thiotepa—urinary bladder cancer	0.000979	0.00238	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000975	0.00237	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000969	0.00235	CcSEcCtD
Dextropropoxyphene—Drowsiness—Methotrexate—urinary bladder cancer	0.000965	0.00234	CcSEcCtD
Dextropropoxyphene—Hypotension—Etoposide—urinary bladder cancer	0.000961	0.00233	CcSEcCtD
Dextropropoxyphene—Dizziness—Thiotepa—urinary bladder cancer	0.000946	0.0023	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000925	0.00225	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Etoposide—urinary bladder cancer	0.000916	0.00223	CcSEcCtD
Dextropropoxyphene—Somnolence—Etoposide—urinary bladder cancer	0.000914	0.00222	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000913	0.00222	CcSEcCtD
Dextropropoxyphene—Vomiting—Thiotepa—urinary bladder cancer	0.00091	0.00221	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ESR1—urinary bladder cancer	0.000907	0.0923	CrCbGaD
Dextropropoxyphene—Drowsiness—Epirubicin—urinary bladder cancer	0.000903	0.00219	CcSEcCtD
Dextropropoxyphene—Rash—Thiotepa—urinary bladder cancer	0.000902	0.00219	CcSEcCtD
Dextropropoxyphene—Dermatitis—Thiotepa—urinary bladder cancer	0.000901	0.00219	CcSEcCtD
Dextropropoxyphene—Headache—Thiotepa—urinary bladder cancer	0.000896	0.00218	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000887	0.00216	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—urinary bladder cancer	0.000881	0.00214	CcSEcCtD
Dextropropoxyphene—Constipation—Etoposide—urinary bladder cancer	0.000879	0.00213	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000872	0.00212	CcSEcCtD
Dextropropoxyphene—Asthenia—Gemcitabine—urinary bladder cancer	0.000864	0.0021	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—PTGS2—urinary bladder cancer	0.000855	0.087	CrCbGaD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000854	0.00208	CcSEcCtD
Dextropropoxyphene—Nausea—Thiotepa—urinary bladder cancer	0.00085	0.00206	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Etoposide—urinary bladder cancer	0.000847	0.00206	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000841	0.00204	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—urinary bladder cancer	0.000836	0.00203	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—urinary bladder cancer	0.000835	0.00203	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000827	0.00201	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—urinary bladder cancer	0.000826	0.00201	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000824	0.002	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—urinary bladder cancer	0.000815	0.00198	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Etoposide—urinary bladder cancer	0.000813	0.00197	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—urinary bladder cancer	0.00081	0.00197	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00081	0.00197	CcSEcCtD
Dextropropoxyphene—Asthenia—Cisplatin—urinary bladder cancer	0.000805	0.00196	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000804	0.00195	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000791	0.00192	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—urinary bladder cancer	0.000783	0.0019	CcSEcCtD
Dextropropoxyphene—Dizziness—Fluorouracil—urinary bladder cancer	0.000783	0.0019	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—urinary bladder cancer	0.000782	0.0019	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000781	0.0019	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Cisplatin—urinary bladder cancer	0.000768	0.00186	CcSEcCtD
Dextropropoxyphene—Vomiting—Gemcitabine—urinary bladder cancer	0.000765	0.00186	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—urinary bladder cancer	0.000764	0.00186	CcSEcCtD
Dextropropoxyphene—Rash—Gemcitabine—urinary bladder cancer	0.000759	0.00184	CcSEcCtD
Dextropropoxyphene—Dermatitis—Gemcitabine—urinary bladder cancer	0.000758	0.00184	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—urinary bladder cancer	0.000758	0.00184	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Etoposide—urinary bladder cancer	0.000757	0.00184	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—urinary bladder cancer	0.000754	0.00183	CcSEcCtD
Dextropropoxyphene—Headache—Gemcitabine—urinary bladder cancer	0.000754	0.00183	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000753	0.00183	CcSEcCtD
Dextropropoxyphene—Vomiting—Fluorouracil—urinary bladder cancer	0.000753	0.00183	CcSEcCtD
Dextropropoxyphene—Rash—Fluorouracil—urinary bladder cancer	0.000746	0.00181	CcSEcCtD
Dextropropoxyphene—Dermatitis—Fluorouracil—urinary bladder cancer	0.000746	0.00181	CcSEcCtD
Dextropropoxyphene—Headache—Fluorouracil—urinary bladder cancer	0.000741	0.0018	CcSEcCtD
Dextropropoxyphene—Asthenia—Etoposide—urinary bladder cancer	0.000738	0.00179	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—urinary bladder cancer	0.000733	0.00178	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000731	0.00178	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—urinary bladder cancer	0.000725	0.00176	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—urinary bladder cancer	0.000723	0.00176	CcSEcCtD
Dextropropoxyphene—Nausea—Gemcitabine—urinary bladder cancer	0.000715	0.00174	CcSEcCtD
Dextropropoxyphene—Vomiting—Cisplatin—urinary bladder cancer	0.000713	0.00173	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—urinary bladder cancer	0.000711	0.00173	CcSEcCtD
Dextropropoxyphene—Rash—Cisplatin—urinary bladder cancer	0.000707	0.00172	CcSEcCtD
Dextropropoxyphene—Dermatitis—Cisplatin—urinary bladder cancer	0.000707	0.00172	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—urinary bladder cancer	0.000706	0.00171	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Etoposide—urinary bladder cancer	0.000703	0.00171	CcSEcCtD
Dextropropoxyphene—Nausea—Fluorouracil—urinary bladder cancer	0.000703	0.00171	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—urinary bladder cancer	0.000701	0.0017	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000696	0.00169	CcSEcCtD
Dextropropoxyphene—Dizziness—Etoposide—urinary bladder cancer	0.00068	0.00165	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000678	0.00165	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000676	0.00164	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00067	0.00163	CcSEcCtD
Dextropropoxyphene—Nausea—Cisplatin—urinary bladder cancer	0.000666	0.00162	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—urinary bladder cancer	0.000665	0.00162	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—urinary bladder cancer	0.000654	0.00159	CcSEcCtD
Dextropropoxyphene—Vomiting—Etoposide—urinary bladder cancer	0.000654	0.00159	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—urinary bladder cancer	0.000653	0.00159	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—urinary bladder cancer	0.000649	0.00158	CcSEcCtD
Dextropropoxyphene—Rash—Etoposide—urinary bladder cancer	0.000648	0.00157	CcSEcCtD
Dextropropoxyphene—Dermatitis—Etoposide—urinary bladder cancer	0.000648	0.00157	CcSEcCtD
Dextropropoxyphene—Headache—Etoposide—urinary bladder cancer	0.000644	0.00156	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—urinary bladder cancer	0.000635	0.00154	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—urinary bladder cancer	0.000633	0.00154	CcSEcCtD
Dextropropoxyphene—Confusional state—Methotrexate—urinary bladder cancer	0.000621	0.00151	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000621	0.00151	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—urinary bladder cancer	0.000616	0.0015	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—urinary bladder cancer	0.000612	0.00149	CcSEcCtD
Dextropropoxyphene—Nausea—Etoposide—urinary bladder cancer	0.000611	0.00148	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000604	0.00147	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—urinary bladder cancer	0.0006	0.00146	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—urinary bladder cancer	0.000594	0.00144	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—urinary bladder cancer	0.000586	0.00142	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—urinary bladder cancer	0.000581	0.00141	CcSEcCtD
Dextropropoxyphene—Hypotension—Methotrexate—urinary bladder cancer	0.000575	0.0014	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000574	0.00139	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—urinary bladder cancer	0.000567	0.00138	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—urinary bladder cancer	0.000566	0.00137	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000565	0.00137	CcSEcCtD
Dextropropoxyphene—Tachycardia—Epirubicin—urinary bladder cancer	0.000562	0.00137	CcSEcCtD
Dextropropoxyphene—Insomnia—Methotrexate—urinary bladder cancer	0.000557	0.00135	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—urinary bladder cancer	0.000549	0.00133	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—urinary bladder cancer	0.000549	0.00133	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—urinary bladder cancer	0.000547	0.00133	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—urinary bladder cancer	0.000542	0.00132	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—urinary bladder cancer	0.000538	0.00131	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—urinary bladder cancer	0.000538	0.00131	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000532	0.00129	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—urinary bladder cancer	0.000525	0.00127	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000523	0.00127	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—urinary bladder cancer	0.000521	0.00127	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—urinary bladder cancer	0.00052	0.00126	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Epirubicin—urinary bladder cancer	0.000514	0.00125	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—urinary bladder cancer	0.000512	0.00124	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000507	0.00123	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—urinary bladder cancer	0.000507	0.00123	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000503	0.00122	CcSEcCtD
Dextropropoxyphene—Hypotension—Doxorubicin—urinary bladder cancer	0.000498	0.00121	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000497	0.00121	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—urinary bladder cancer	0.000493	0.0012	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—urinary bladder cancer	0.000487	0.00118	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—urinary bladder cancer	0.000482	0.00117	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000475	0.00115	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000475	0.00115	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—urinary bladder cancer	0.000474	0.00115	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000471	0.00114	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000469	0.00114	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00046	0.00112	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—urinary bladder cancer	0.000456	0.00111	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—urinary bladder cancer	0.000456	0.00111	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000454	0.0011	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—urinary bladder cancer	0.000442	0.00107	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000439	0.00107	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000436	0.00106	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000425	0.00103	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000421	0.00102	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—urinary bladder cancer	0.000421	0.00102	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—urinary bladder cancer	0.000413	0.001	CcSEcCtD
Dextropropoxyphene—Dizziness—Methotrexate—urinary bladder cancer	0.000407	0.000989	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—urinary bladder cancer	0.000394	0.000958	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000393	0.000954	CcSEcCtD
Dextropropoxyphene—Vomiting—Methotrexate—urinary bladder cancer	0.000391	0.000951	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—urinary bladder cancer	0.000388	0.000943	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—urinary bladder cancer	0.000388	0.000942	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—urinary bladder cancer	0.000386	0.000937	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—urinary bladder cancer	0.000383	0.000929	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—urinary bladder cancer	0.000381	0.000925	CcSEcCtD
Dextropropoxyphene—Vomiting—Epirubicin—urinary bladder cancer	0.000366	0.00089	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—urinary bladder cancer	0.000366	0.000888	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000365	0.000886	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—urinary bladder cancer	0.000363	0.000882	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—urinary bladder cancer	0.000363	0.000882	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—urinary bladder cancer	0.000361	0.000877	CcSEcCtD
Dextropropoxyphene—Dizziness—Doxorubicin—urinary bladder cancer	0.000353	0.000856	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—urinary bladder cancer	0.000342	0.000831	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—urinary bladder cancer	0.000339	0.000823	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—urinary bladder cancer	0.000336	0.000816	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—urinary bladder cancer	0.000336	0.000816	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—urinary bladder cancer	0.000334	0.000811	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—urinary bladder cancer	0.000317	0.000769	CcSEcCtD
Dextropropoxyphene—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	0.000125	0.000928	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000122	0.0009	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	0.000119	0.00088	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NAT1—urinary bladder cancer	0.000119	0.00088	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000118	0.000876	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000117	0.000866	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.000115	0.000852	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GLI1—urinary bladder cancer	0.000112	0.000828	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.00011	0.000813	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	0.000109	0.000805	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000108	0.000802	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000107	0.000789	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NAT2—urinary bladder cancer	0.000104	0.00077	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RBX1—urinary bladder cancer	0.000103	0.000766	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000103	0.000762	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000102	0.000756	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000101	0.000747	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.96e-05	0.000737	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	9.79e-05	0.000725	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	9.76e-05	0.000722	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NAT1—urinary bladder cancer	9.76e-05	0.000722	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TSC1—urinary bladder cancer	9.73e-05	0.00072	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	9.68e-05	0.000716	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NAT1—urinary bladder cancer	9.68e-05	0.000716	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.52e-05	0.000704	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—JAG1—urinary bladder cancer	9.26e-05	0.000685	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	9.25e-05	0.000684	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RBX1—urinary bladder cancer	9.07e-05	0.000671	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—CXCL8—urinary bladder cancer	9.01e-05	0.000667	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	9.01e-05	0.000667	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—RRM2—urinary bladder cancer	8.98e-05	0.000665	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	8.93e-05	0.000661	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	8.85e-05	0.000655	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TSC1—urinary bladder cancer	8.53e-05	0.000631	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	8.32e-05	0.000616	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ENO2—urinary bladder cancer	8.32e-05	0.000616	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—JAG1—urinary bladder cancer	8.12e-05	0.000601	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	8.07e-05	0.000597	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	8.04e-05	0.000595	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	7.97e-05	0.00059	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—RHOA—urinary bladder cancer	7.83e-05	0.000579	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	7.67e-05	0.000567	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	7.59e-05	0.000562	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	7.53e-05	0.000557	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—S100B—urinary bladder cancer	7.5e-05	0.000555	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.4e-05	0.000548	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	7.33e-05	0.000543	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.23e-05	0.000535	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	7.21e-05	0.000534	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TYMP—urinary bladder cancer	7.2e-05	0.000533	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—RHOA—urinary bladder cancer	7.11e-05	0.000526	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.92e-05	0.000512	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.87e-05	0.000509	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—RHOA—urinary bladder cancer	6.86e-05	0.000508	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	6.86e-05	0.000508	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—NCOR1—urinary bladder cancer	6.74e-05	0.000499	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.73e-05	0.000498	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NQO1—urinary bladder cancer	6.71e-05	0.000496	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—S100B—urinary bladder cancer	6.58e-05	0.000487	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—IL2—urinary bladder cancer	6.57e-05	0.000486	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NAT2—urinary bladder cancer	6.52e-05	0.000482	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.38e-05	0.000472	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.38e-05	0.000472	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	6.24e-05	0.000462	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—RHOA—urinary bladder cancer	6.23e-05	0.000461	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.03e-05	0.000446	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—IL2—urinary bladder cancer	5.96e-05	0.000441	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TERT—urinary bladder cancer	5.94e-05	0.00044	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.91e-05	0.000438	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—NCOR1—urinary bladder cancer	5.91e-05	0.000438	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.88e-05	0.000435	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TYMP—urinary bladder cancer	5.86e-05	0.000434	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.84e-05	0.000432	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	5.8e-05	0.000429	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—IL2—urinary bladder cancer	5.76e-05	0.000426	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.63e-05	0.000417	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—RRM2—urinary bladder cancer	5.62e-05	0.000416	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	5.59e-05	0.000414	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	5.56e-05	0.000411	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CXCL8—urinary bladder cancer	5.47e-05	0.000405	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—FGFR3—urinary bladder cancer	5.45e-05	0.000404	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.35e-05	0.000396	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NAT2—urinary bladder cancer	5.3e-05	0.000392	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ESR1—urinary bladder cancer	5.3e-05	0.000392	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	5.27e-05	0.00039	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.26e-05	0.000389	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—IL2—urinary bladder cancer	5.23e-05	0.000387	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TERT—urinary bladder cancer	5.21e-05	0.000386	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	5.21e-05	0.000385	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ENO2—urinary bladder cancer	5.21e-05	0.000385	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—TYMS—urinary bladder cancer	5.2e-05	0.000385	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.18e-05	0.000383	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	5.14e-05	0.00038	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	5.14e-05	0.00038	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.09e-05	0.000377	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	5.05e-05	0.000374	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	5e-05	0.00037	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.97e-05	0.000368	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.96e-05	0.000367	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GPX1—urinary bladder cancer	4.92e-05	0.000364	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	4.87e-05	0.00036	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.84e-05	0.000358	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	4.83e-05	0.000358	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—FGFR3—urinary bladder cancer	4.78e-05	0.000354	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ESR1—urinary bladder cancer	4.64e-05	0.000344	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CREBBP—urinary bladder cancer	4.64e-05	0.000344	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	4.63e-05	0.000342	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.62e-05	0.000342	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IGF1—urinary bladder cancer	4.58e-05	0.000339	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.58e-05	0.000339	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—EGFR—urinary bladder cancer	4.56e-05	0.000338	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	4.54e-05	0.000336	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	4.42e-05	0.000327	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	4.4e-05	0.000326	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—KRAS—urinary bladder cancer	4.31e-05	0.000319	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.28e-05	0.000316	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.28e-05	0.000316	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.24e-05	0.000314	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.24e-05	0.000314	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.21e-05	0.000312	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—RHOA—urinary bladder cancer	4.2e-05	0.000311	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NQO1—urinary bladder cancer	4.2e-05	0.000311	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.15e-05	0.000307	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	4.11e-05	0.000304	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.07e-05	0.000301	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CREBBP—urinary bladder cancer	4.07e-05	0.000301	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.05e-05	0.0003	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	4.04e-05	0.000299	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF1—urinary bladder cancer	4.02e-05	0.000297	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EGFR—urinary bladder cancer	4e-05	0.000296	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	3.93e-05	0.00029	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ERBB2—urinary bladder cancer	3.89e-05	0.000288	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.87e-05	0.000286	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—KRAS—urinary bladder cancer	3.78e-05	0.00028	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CXCL8—urinary bladder cancer	3.69e-05	0.000273	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PPARG—urinary bladder cancer	3.68e-05	0.000273	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—RHOA—urinary bladder cancer	3.68e-05	0.000273	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—HRAS—urinary bladder cancer	3.66e-05	0.000271	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.55e-05	0.000263	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	3.54e-05	0.000262	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IL2—urinary bladder cancer	3.52e-05	0.000261	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.5e-05	0.000259	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.5e-05	0.000259	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.45e-05	0.000255	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	3.44e-05	0.000255	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CCND1—urinary bladder cancer	3.43e-05	0.000254	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.42e-05	0.000253	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ERBB2—urinary bladder cancer	3.41e-05	0.000252	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	3.4e-05	0.000251	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.39e-05	0.000251	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	3.38e-05	0.00025	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MMP9—urinary bladder cancer	3.33e-05	0.000247	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	3.32e-05	0.000246	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.32e-05	0.000245	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PTEN—urinary bladder cancer	3.32e-05	0.000245	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—TYMS—urinary bladder cancer	3.26e-05	0.000241	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CXCL8—urinary bladder cancer	3.23e-05	0.000239	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	3.22e-05	0.000238	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	3.22e-05	0.000238	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—HRAS—urinary bladder cancer	3.21e-05	0.000238	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	3.19e-05	0.000236	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EP300—urinary bladder cancer	3.16e-05	0.000234	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	3.11e-05	0.00023	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IL2—urinary bladder cancer	3.09e-05	0.000229	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.08e-05	0.000228	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SRC—urinary bladder cancer	3.07e-05	0.000228	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	3.03e-05	0.000224	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.02e-05	0.000223	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CCND1—urinary bladder cancer	3.01e-05	0.000223	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MMP9—urinary bladder cancer	2.92e-05	0.000216	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.91e-05	0.000216	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PTEN—urinary bladder cancer	2.91e-05	0.000215	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.9e-05	0.000214	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.89e-05	0.000214	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	2.88e-05	0.000213	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.87e-05	0.000213	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.85e-05	0.000211	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.84e-05	0.00021	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.8e-05	0.000207	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.8e-05	0.000207	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EP300—urinary bladder cancer	2.77e-05	0.000205	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.76e-05	0.000204	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MYC—urinary bladder cancer	2.76e-05	0.000204	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	2.73e-05	0.000202	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	2.71e-05	0.000201	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.71e-05	0.000201	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SRC—urinary bladder cancer	2.7e-05	0.0002	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—urinary bladder cancer	2.69e-05	0.000199	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.67e-05	0.000198	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.65e-05	0.000196	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.64e-05	0.000196	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.64e-05	0.000196	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.62e-05	0.000194	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.62e-05	0.000194	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	2.61e-05	0.000193	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—KRAS—urinary bladder cancer	2.55e-05	0.000188	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	2.55e-05	0.000188	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.53e-05	0.000187	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.53e-05	0.000187	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.51e-05	0.000186	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.48e-05	0.000184	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	2.47e-05	0.000183	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.46e-05	0.000182	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.46e-05	0.000182	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	2.46e-05	0.000182	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	2.42e-05	0.000179	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.41e-05	0.000178	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	2.36e-05	0.000175	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	2.34e-05	0.000173	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.33e-05	0.000173	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.31e-05	0.000171	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.31e-05	0.000171	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	2.28e-05	0.000169	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—urinary bladder cancer	2.26e-05	0.000167	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.25e-05	0.000167	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	2.23e-05	0.000165	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.22e-05	0.000164	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—HRAS—urinary bladder cancer	2.16e-05	0.00016	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	2.04e-05	0.000151	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	2e-05	0.000148	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	1.98e-05	0.000147	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	1.9e-05	0.00014	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.89e-05	0.00014	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	1.89e-05	0.00014	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.88e-05	0.000139	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.88e-05	0.000139	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.82e-05	0.000135	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.81e-05	0.000134	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.8e-05	0.000133	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.75e-05	0.000129	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.73e-05	0.000128	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.73e-05	0.000128	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	1.68e-05	0.000124	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.65e-05	0.000122	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.62e-05	0.00012	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	1.6e-05	0.000119	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.58e-05	0.000117	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.53e-05	0.000113	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.51e-05	0.000112	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.49e-05	0.00011	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.48e-05	0.000109	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.3e-05	9.61e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.29e-05	9.53e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.24e-05	9.17e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.24e-05	9.16e-05	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.23e-05	9.09e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.19e-05	8.8e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.74e-06	7.21e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.49e-06	6.28e-05	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.1e-06	5.99e-05	CbGpPWpGaD
